Lancashire and South Cumbria
Formulary
Home
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Canagliflozin
found
7 matches
Open monograph to display formulary status
BNF Category
Canagliflozin
(Invokana
®
)
Endocrine system - SGLT2 inhibitors - 06.01.02.03
Canagliflozin
/ metformin IR Vokanamet
Endocrine system - SGLT2 inhibitors - 06.01.02.03
Links
Link to Drug Section
Link to document
MHRA Drug Safety update June 2015: SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin): risk of diabetic ketoacidosis (06.01.02.03)
NICE TA315: Canagliflozin in combination therapy for treating type 2 diabetes (06.01.02.03)
NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
